文献速递头颈部肿瘤放疗

口咽癌放疗后晚期味觉损伤动力学的同期观察性研究

Prospective observational evaluation of radiation-induced late taste impairment kinetics in oropharyngeal cancer patients: Potential for improvement over time?
PubMed 文献 · Clin Transl Radiat Oncol · 2020-03-24

该前瞻性观察研究纳入326例接受调强放疗或容积旋转调强放疗的口咽癌患者,分析放疗结束1至13年间的1214份MDASI-HN味觉条目数据。结果显示味觉损伤在放疗后最初几年明显改善,但5年后趋于稳定;多因素分析显示放疗后第6年治疗部位、第7年CTV1剂量和年龄为显著影响因素。

要点

  • 口咽癌放疗后晚期味觉损伤在最初几年明显改善,但5年后趋于稳定。
  • 第2至第3年味觉损伤显著减轻(p=0.001),第3至第4年接近显著(p=0.058)。
  • 放疗后第6年治疗部位、第7年CTV1剂量和年龄为显著影响因素。

核心结论

  • 放疗诱导的味觉损伤可能在较长时间内改善,但放疗后第5年起相对稳定。
  • 直接描述放疗诱导味觉损伤及计算正常组织并发症概率时应考虑味觉恢复的时间依赖过程。

研究设计与样本

  • IRB批准的前瞻性观察研究,纳入接受调强放疗或容积旋转调强放疗且放疗结束≥1年后至少完成两次味觉评估的口咽癌患者。
  • 共纳入326例患者的1214份MDASI-HN味觉条目,覆盖放疗后1至13年。
  • CTV1中位处方剂量为66.0 Gy,180例(55%)接受化疗。

主要发现

  • 味觉损伤在放疗结束后最初几年明显改善,但第5年后趋于平台。
  • 在后续年份有味觉评估的患者中,第2至第3年味觉损伤显著减轻(p=0.001),第3至第4年接近显著(p=0.058)。
  • 多因素分析显示放疗后第6年治疗部位为显著因素,第7年CTV1剂量和年龄为显著因素。

临床怎么用

  • 口咽癌放疗后味觉损伤的随访和评估应覆盖5年以上,以捕捉晚期恢复过程。
  • 正常组织并发症概率模型可将放疗后时间依赖的味觉恢复纳入考量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Taste impairment is a common radiation-induced toxicity in head and neck cancer (HNC) patients acutely. However, data on the potential for recovery and the time dependent course of late taste impairment are limited. MATERIALS AND METHODS: As part of an IRB-approved observational prospective study, HNC patients underwent serial surveys including the MD Anderson Symptom Inventory - Head and Neck module (MDASI-HN). For our analysis, we extracted MDASI-HN taste item results from oropharyngeal cancer patients treated with intensity-modulated radiotherapy or volumetric modulated arc therapy and at least two taste assessments after ≥1 year from end of radiotherapy (RT). RESULTS: 1214 MDASI taste items from 326 patients between 1 and 13 years post-RT were included. Median prescribed dose to the high-dose clinical target volume (CTV1) was 66.0 Gy, with 180 patients (55%) receiving chemotherapy. Taste markedly improved in the first years from end of RT, but plateaued after year 5. In patients with taste assessment in subsequent years, a significant reduction in taste impairment was found from the second to the third year (p = 0.001) and tended towards significance from the third to the fourth year (p = 0.058). Multivariate analysis revealed treatment site as significant factor in the sixth year from RT and CTV1 dose and age in the seventh year. CONCLUSION: Radiation-induced taste impairment may improve over an extended time interval, but becomes relatively stable from year 5 post-RT. Direct characterization of RT-induced taste impairment and the calculation of normal tissue complication probability should include consideration of the time-dependent course in taste recovery.

来源:Clin Transl Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Stieb S, Mohamed ASR, Deshpande TS, et al. Prospective observational evaluation of radiation-induced late taste impairment kinetics in oropharyngeal cancer patients: Potential for improvement over time? Clin Transl Radiat Oncol. 2020. PMID: 32373720. doi:10.1016/j.ctro.2020.03.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。